Navigation Links
Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
Date:11/11/2008

EMERYVILLE, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective drugs in the areas of women's health and cancer, announced that Isaac Cohen, Chairman and CEO of Bionovo, will be presenting an overview of the Company at the Rodman & Renshaw 10th Annual Global Investment Conference on November 11, 2008 at 5:45 p.m. Eastern Time. The event will be held at the New York Palace Hotel in New York City.

The presentation will be webcast and can be viewed via Bionovo's website at http://bionovo.com/investors/events. A webcast replay will become available shortly after the presentation ends and will continue to be accessible for 90 days via Bionovo's website.

About Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol BNVI. For more information about Bionovo and its programs, visit http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. John D. Baxter, M.D. Joins Bionovos Board of Directors
2. Bionovo to Present at the Cambria Capital Investor Meeting
3. Bionovo Announces 2007 Financial Results and Highlights
4. Bionovo Describes a New Class of Therapeutic Compounds
5. Bionovo Announces Closing of Public Offering of Common Stock
6. ProAssurance to Present at Oppenheimer Investor Conference
7. Healthcare Partners Medical Group to Host Free Medicare Benefits Presentations
8. ProteoTech to Present at Rodman & Renshaws 10th Annual Healthcare Conference
9. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
10. Wyeth to Present at the Credit Suisse Healthcare Conference
11. Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 19, 2017 , ... Curl Keeper® is excited to announce ... Leaders, Editors’ Choice 2017 Award for the second year in a row. The H2O ... curlies alike was voted Best Moisturizer for Type 2 Wavies and Best Refresher for ...
(Date:8/19/2017)... ... 2017 , ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: ... God. “Congratulations! It's A Boy! God’s Gift: A Story of Love” is the creation ... York. , Published by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... “Vision & Hearing” campaign, advocating for active, healthy lifestyles and highlighting the importance ... for individuals with hearing impairments and shares the latest innovations in hearing aid ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... and financial consultations to communities throughout the greater DC region, is inaugurating a ... goal of rescuing local animals and training them to be companions for veterans ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and financial planning firm that serves residential and commercial clients in the greater ... drive to raise community support for the fight against cancer. , Founded by ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/7/2017)... Aug. 7, 2017 Insightin Health, provider ... retention, and engagement, announced the selection of ... Product Development, effective as of February 2017. In this ... implementation strategy for our clients. Wood brings with ... consulting and business analytics within the healthcare industry. ...
Breaking Medicine Technology: